Baseline characteristics | VZV disease characteristics | Impact on immunosuppressive treatment | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Sex/Age (years) | Diagnosis | Medication at onset of VZV | VZV vaccine doses | Time to event (months) | Date of onset | Rash | Complications | Hosp. | Treatment | Dur. | Management of immunosuppression |
Varicella | ||||||||||||
1 | F/4.8 | JIA | MTX | 0 | 15.1 | 05/2004 | typical | cellulitis | 6d | ACV i.v. + AB | 7d | unknown |
2 | F/6.3 | JIA | MTX | 0 | 14.9 | 06/2005 | typical | none | no | no | - | continued |
3 | F/6.3 | JIA | MTX | 0 | 14.2 | 01/2006 | typical | none | no | no | - | continued |
4 | F/3.0 | JIA | MTX | 0 | 6.2 | 01/2007 | typical | none | no | no | - | continued |
5 | F/6.1 | JIA | MTX + INF | 0 | 17.6 | 02/2008 | typical | cellulitis, sepsis | 9d | ACV i.v. + AB | 7d | interrupted |
6 | F/3.7 | JIA | ETA | 0 | 4.2 | 02/2009 | typical | none | no | ACV i.v. | n.a. | interrupted |
7 | F/3.4 | JIA | MTX + ETA | 0 | 8.6 | 04/2009 | typical | none | no | no | - | interrupted |
8 | F/2.5 | JIA | ETA | 0 | 4.4 | 03/2010 | typical | cellulitis | no | ACV p.o. + AB | 7d | continued |
9 | F/17.4 | JIA | MTX | 1 | 29.9 | 10/2010 | typical | none | no | no | - | continued |
10 | M/8.9 | JIA | MTX + ADA | 0 | 21.7 | 02/2011 | typical | cerebellitis | 5d | ACV i.v. | 7d | continued |
11 | M/8.8 | JIA | MTX + INF | 0a | 5.7 | 04/2011 | atypical | none | no | no | - | continued |
12 | F/7.2 | JIA | MTX | 0 | 3 | 02/2012 | typical | none | 5d | ACV i.v. | 5d | interrupted |
13 | F/6.2 | JIA | MTX + TCZ | 0 | 1.1 | 03/2012 | atypical | none | no | ACV p.o. | 8d | interrupted |
14 | M/4.0 | JIA | MTX | 0 | 12.4 | 04/2012 | atypical | none | no | VCV p.o. | 7d | interrupted |
15 | M/4.1 | JIA | TCZ + Pred. | 0 | 3.2 | 06/2012 | typical | none | 6d | ACV i.v. | 6d | interrupted |
16 | M/7.5 | JIA | MTX + INF | 1 | 30.3 | 04/2013 | atypical | none | no | ACV i.v. + p.o. | 7d | interrupted |
Herpes zoster | ||||||||||||
17 | F/6.4 | JIA | MTX | 0 | 5.5 | 04/2004 | n.a. | none | no | no | - | continued |
18 | F/14.7 | JIA | MTX + ADA | 0 | 10.9 | 10/2004 | n.a. | none | no | no | - | continued |
19 | F/5.9 | JIA | MTX | 0 | 4.1 | 01/2005 | n.a. | none | no | no | - | continued |
20 | M/13.6 | PAS III | RTX + Pred. | 0 | 6 | 12/2008 | n.a. | none | no | no | - | continued |
21 | F/9.5 | JIA | LEF + INF | 0 | 27.6 | 07/2011 | Lumbar 1, left | none | no | VCV p.o. | n.a. | interrupted |
22 | F/16.5 | Ant. Uv. | MTX + INF | 0 | 63 | 11/2013 | Trigeminal ophthalmic nerve, left | none | 4d | ACV iv. + p.o.b | 7d | interrupted |